| NDC Code: |
10139-062 |
| Proprietary Name: |
Methotrexate |
| Suffix: |
|
| Non-Proprietary Name: |
Methotrexate |
| Dosage Form: |
INJECTION, SOLUTION |
| Method: |
INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
| Original Marketing Date: |
06-05-2013 |
| End of Marketing: |
31-01-2014 |
| Category Name: |
ANDA |
| Application Number: |
ANDA040716 |
| Labeler: |
GENERAMEDIX |
| Substance Name: |
METHOTREXATE |
| Active Numerator Strength: |
25 |
| Active Ingredient Unit: |
mg/mL |
| Pharm Classes: |
Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
| DEA Schedule: |
|
